Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.
Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Maverakis E, et al. Among authors: williams hc. JAMA Dermatol. 2018 Apr 1;154(4):461-466. doi: 10.1001/jamadermatol.2017.5980. JAMA Dermatol. 2018. PMID: 29450466 Free article.
UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Craig FF, Thomas KS, Mitchell EJ, Williams HC, Norrie J, Mason JM, Ormerod AD; UK Dermatology Clinical Trials Network’s STOP GAP Trial Team. Craig FF, et al. Among authors: williams hc. Trials. 2012 Apr 28;13:51. doi: 10.1186/1745-6215-13-51. Trials. 2012. PMID: 22540770 Free PMC article. Clinical Trial.
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC; UK Dermatology Clinical Trials Network’s STOP GAP Team. Ormerod AD, et al. Among authors: williams hc. BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958. BMJ. 2015. PMID: 26071094 Free PMC article. Clinical Trial.
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.
Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC; UK Dermatology Clinical Trials Network's STOP GAP Team. Thomas KS, et al. Among authors: williams hc. J Am Acad Dermatol. 2016 Nov;75(5):940-949. doi: 10.1016/j.jaad.2016.06.016. Epub 2016 Aug 5. J Am Acad Dermatol. 2016. PMID: 27502313
Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?
Wilkes SR, Williams HC, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell EJ, Mason JM, Thomas KS; United Kingdom Dermatology Clinical Trials Network STOP GAP team. Wilkes SR, et al. Among authors: williams hc. J Am Acad Dermatol. 2016 Dec;75(6):1216-1220.e2. doi: 10.1016/j.jaad.2016.07.049. Epub 2016 Oct 11. J Am Acad Dermatol. 2016. PMID: 27742168
New validated diagnostic criteria for pyoderma gangrenosum.
Maverakis E, Le ST, Callen J, Wollina U, Marzano AV, Wallach D, Schadt C, Martinez-Alvarado YC, Cheng MY, Ma C, Merleev A, Ormerod A, Craig F, Jockenhofer F, Dissemond J, Salva K, Williams HC, Fiorentino D. Maverakis E, et al. Among authors: williams hc. J Am Acad Dermatol. 2019 Apr;80(4):e87-e88. doi: 10.1016/j.jaad.2018.08.068. Epub 2018 Dec 14. J Am Acad Dermatol. 2019. PMID: 30557582 Free article. No abstract available.
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, Spuls PI, Thomas KS, Howells L, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Leshem YA, et al. Among authors: williams hc. JAMA Dermatol. 2022 Dec 1;158(12):1429-1435. doi: 10.1001/jamadermatol.2022.4211. JAMA Dermatol. 2022. PMID: 36223090
Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews.
Karimkhani C, Boyers LN, Prescott L, Welch V, Delamere FM, Nasser M, Zaveri A, Hay RJ, Vos T, Murray CJ, Margolis DJ, Hilton J, MacLehose H, Williams HC, Dellavalle RP. Karimkhani C, et al. Among authors: williams hc. JAMA Dermatol. 2014 Sep;150(9):945-51. doi: 10.1001/jamadermatol.2014.709. JAMA Dermatol. 2014. PMID: 24807687
A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.
Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, Foster KA, Whitham D, Williams HC; BLISTER study group. Chalmers JR, et al. Among authors: williams hc. Br J Dermatol. 2015 Jul;173(1):227-34. doi: 10.1111/bjd.13729. Epub 2015 May 26. Br J Dermatol. 2015. PMID: 25683592 Clinical Trial.
558 results